Press Releases Bionano Genomics, Inc.

Equities

BNGO

US09075F3055

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
0.7861 ^USD	+3.57%		+4.81%	-58.41%

Apr. 17	Bionano Genomics, Hangzhou Diagens Biotechnology to Commercialize Cytogenetic Workflow for Reproductive Health	MT
Apr. 17	Bionano Genomics, Inc. and Hangzhou Diagens Biotechnology Co., Ltd. Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis That Combines OGM and Artificial Intelligence	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bionano Announces Publication Showing OGM's High Resolution Structural Variation Detection in Cancer Validated by Cas9-Directed Nanopore Sequencing	Apr. 25	AQ
Bionano Announces Publication Showing OGM’s High Resolution Structural Variation Detection in Cancer Validated by Cas9-Directed Nanopore Sequencing	Apr. 24	AQ
Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis that Combines OGM and Artificial Intelligence	Apr. 17	AQ
Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing	Apr. 11	AQ
Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules	Apr. 04	AQ
Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical Cytogenetics	Apr. 03	AQ
Bionano Announces 9 Poster Presentations and Introduces New High Throughput Stratys™ System at the American Association for Cancer Research Annual Meeting	Apr. 02	AQ
Bionano Announces Publication of a Breast Cancer Study Showing that the Number of SVs Detected with OGM May Be Related to Prognosis, Tumor Progression and Chemotherapy Resistance	Mar. 19	AQ
Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Including Live Product Showcase Featuring the Company’s New Stratys™ System	Mar. 07	AQ
Bionano Reports Fourth Quarter and Full-Year 2023 Results and Provides Revenue Outlook for 2024	Mar. 05	AQ
Bionano to Present at TD Cowen’s 44th Annual Health Care Conference	Feb. 29	AQ
Bionano to Report Fourth Quarter and Year End 2023 Financial Results and Host a Conference Call and Webcast on March 5, 2024	Feb. 28	AQ
Bionano Announces Amendment to Debt Financing Arrangement to Extend Cash Runway	Feb. 28	AQ
American College of Medical Genetics and Genomics Includes OGM in Latest Edition of Technical Laboratory Standards for Solid Tumor Analysis	Feb. 22	AQ
Bionano to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference	Jan. 31	AQ
Bionano’s Symposium 2024 Featured Presentations from its Global User Community Highlighting OGM as a Powerful Alternative to Classical Cytogenetics and Strong Complement to NGS	Jan. 30	AQ
Bionano Announces Publication of a Study that Applied OGM to Discovery of Structural Variants Driving Drug Resistance and Sensitivity in Cancer	Jan. 25	AQ
Bionano Announces Publication of Interim Readout from Second Phase of Clinical Trial Analyzing Optical Genome Mapping as Standard of Care (SOC) for Prenatal Testing	Jan. 24	AQ
Bionano Announces Full Commercial Release of the Stratys™ System for High Throughput Optical Genome Mapping	Jan. 23	AQ
Bionano Announces the Final Speaker Lineup for 2024 Symposium with 33 OGM Presentations and Live Panel Discussions Across a Wide Range of Research Applications	Jan. 19	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Bionano Genomics, Inc.

Equities

BNGO

US09075F3055

Press Releases

Filters